Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001697616-26-000002

Chief Financial Officer sold 1,797 shares at $26.28 ($47,225)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Lucera Erick Chief Financial Officer 2026-08-13 Sale 10b5-1 −1,797 $26.28 $47,225 119,766 D
Open-market sales · 1,797 sh · avg $26.28 · $47,225
Loading xslF345X06/ownership.xml…